Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis

F. Everest, M. Tariq, A. De Soyza, A. Perry, J. Perry, S. Bourke, S. Cummings, C. Lanyon, D. Smith (Newcastle upon Tyne, United Kingdom)

Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Session: Cystic fibrosis: basic science, physiology and clinical aspects
Session type: Poster Discussion
Number: 1961
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Everest, M. Tariq, A. De Soyza, A. Perry, J. Perry, S. Bourke, S. Cummings, C. Lanyon, D. Smith (Newcastle upon Tyne, United Kingdom). Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 1961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Vern Rodriguez (Mountain View, United States of America) - 09.09.2014 23:39
Please send me a copy (PDF) of your poster. Thank you vernamanty@gmail.com
You must Login to comment this presentation.


Related content which might interest you:
Microevolution of pseudomonas aeruginosa in cystic fibrosis lungs
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Cystic fibrosis
Source: Respipedia Article
Year: 2018

Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Does the cystic fibrosis phlegm feed the pseudomonas?
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017




Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016


Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015

Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019


Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Airway iron and iron-regulatory cytokines in cystic fibrosis
Source: Eur Respir J 2004; 24: 286-291
Year: 2004



Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018



Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003